{"id":"https://openalex.org/W4247348366","doi":"https://doi.org/10.1158/1538-7445.am2019-324","title":"Abstract 324: BRAF/MEK inhibitors selectively prime melanoma for Mcl-1 dependence and sensitize to Mcl-1 inhibition","display_name":"Abstract 324: BRAF/MEK inhibitors selectively prime melanoma for Mcl-1 dependence and sensitize to Mcl-1 inhibition","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4247348366","doi":"https://doi.org/10.1158/1538-7445.am2019-324"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-324","doi":"https://doi.org/10.1158/1538-7445.am2019-324","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-324","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077345662","display_name":"Karson J. Kump","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karson J. Kump","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103273899","display_name":"Lei Miao","orcid":"https://orcid.org/0000-0002-5031-5698","observed_orcids":["https://orcid.org/0000-0002-5031-5698"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Miao","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012716830","display_name":"Nurul H. Ansari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nurul Ansari","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082825241","display_name":"David B. Lombard","orcid":"https://orcid.org/0000-0002-4292-0185","observed_orcids":["https://orcid.org/0000-0002-4292-0185"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David B. Lombard","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061886518","display_name":"Zaneta Nikolovska\u2010Coleska","orcid":"https://orcid.org/0000-0001-6688-4206","observed_orcids":["https://orcid.org/0000-0001-6688-4206"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zaneta Nikolovska-Coleska","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"324","last_page":"324"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.5512999892234802,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.5512999892234802,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.44020000100135803,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.8550000190734863},{"id":"https://openalex.org/keywords/vemurafenib-resistance","display_name":"vemurafenib resistance","score":0.9020000100135803},{"id":"https://openalex.org/keywords/braf-mek-inhibitors","display_name":"BRAF/MEK inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7350000143051147},{"id":"https://openalex.org/keywords/bh3-profiling","display_name":"BH3 profiling","score":0.8550000190734863},{"id":"https://openalex.org/keywords/mcl-1-inhibitors","display_name":"Mcl-1 inhibitors","score":0.8240000009536743},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6269999742507935},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.7319999933242798},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.6679999828338623},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.6340000033378601},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/targeted-therapy-resistance","display_name":"targeted therapy resistance","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9877424836158752},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7784585952758789},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6925765872001648},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.537808358669281},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5289316773414612},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4459435045719147},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2453218698501587},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.15924271941184998},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.13784044981002808},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.11339658498764038},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06505739688873291}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-324","doi":"https://doi.org/10.1158/1538-7445.am2019-324","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-324","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2563532854","https://openalex.org/W1868879889","https://openalex.org/W2056327493","https://openalex.org/W4323314184","https://openalex.org/W6962377331","https://openalex.org/W2331057589","https://openalex.org/W2344670011","https://openalex.org/W2058390096","https://openalex.org/W2768589575","https://openalex.org/W2076946770"],"abstract_inverted_index":{"Abstract":[0],"Frontline":[1],"treatment":[2,188],"for":[3,170,196,311,349,364],"patients":[4,32,313],"diagnosed":[5],"with":[6,189,206,279,314],"metastatic":[7],"melanoma":[8,118,142,161,181,216,276,348],"harboring":[9],"a":[10,15,61,67,74,102,122,201,262,307],"V600":[11],"BRAF":[12,69],"mutation":[13],"is":[14,43,328],"combination":[16,252,324],"of":[17,31,82,88,95,112,136,150,247,253,287,322,360],"BRAF/MEK":[18,84,344],"inhibitors.":[19,281],"Despite":[20],"advances":[21],"in":[22,46,76,79,138,141,244,275,319],"targeted":[23],"therapies":[24,325],"used":[25],"to":[26,36,65,110,165,185,222,270,354],"treat":[27],"melanoma,":[28],"the":[29,80,96,134,153,245,251,285,320,361],"majority":[30],"will":[33],"relapse":[34],"due":[35],"acquired":[37],"resistance.":[38,86],"The":[39,54],"intrinsic":[40],"apoptotic":[41],"pathway":[42],"frequently":[44],"dysregulated":[45],"cancer,":[47],"promoting":[48],"cell":[49,119,143,162,182,217],"survival":[50],"and":[51,71,106,147,212,228,255,267,293,317,352],"resistance":[52,63,140,327],"mechanisms.":[53],"anti-apoptotic":[55,97,126],"Mcl-1":[56,137,171,195,223,230,256,265,271,291,305,350,355],"protein":[57],"was":[58,273],"identified":[59],"as":[60,200,259],"key":[62],"factor":[64],"vemurafenib,":[66],"mutant":[68],"inhibitor,":[70],"likely":[72],"plays":[73],"role":[75,135],"preventing":[77],"apoptosis":[78,89,248,288],"context":[81],"dual":[83],"inhibitor":[85],"Activation":[87],"by":[90,236,250,290],"using":[91,145,226,232],"small":[92],"molecule":[93],"inhibitors":[94,234,257,272,292,345],"Bcl-2":[98],"proteins":[99],"has":[100],"become":[101],"validated":[103,294],"therapeutic":[104,309],"approach":[105],"can":[107],"re-sensitize":[108],"cancers":[109],"standard":[111],"care":[113],"treatments.":[114],"We":[115,239,282],"found":[116],"that":[117,160,180,303],"lines":[120,144,163,183,218],"display":[121],"heterogeneous":[123],"dependency":[124,193],"on":[125],"proteins.":[127],"In":[128,261],"this":[129],"study,":[130],"we":[131,158,178],"systematically":[132],"investigated":[133],"vemurafenib":[139,166,190,210,214,254],"genetic":[146,224],"pharmacological":[148],"inhibition":[149,231,356],"Mcl-1.":[151],"Using":[152],"functional":[154],"BH3":[155,176],"profiling":[156,177],"assay,":[157],"discovered":[159],"resistant":[164,211,315],"are":[167],"increasingly":[168],"primed":[169],"dependence.":[172],"Additionally,":[173],"applying":[174],"dynamic":[175],"demonstrated":[179],"subjected":[184],"short":[186],"term":[187],"showed":[191],"greater":[192],"upon":[194],"survival,":[197],"thus":[198],"serving":[199],"selective":[202],"priming":[203,266],"agent.":[204],"Consistent":[205],"these":[207],"findings,":[208],"both":[209],"short-term":[213],"pre-treated":[215,278],"displayed":[219],"increased":[220,268],"sensitivity":[221,269],"silencing":[225],"siRNA":[227],"direct":[229],"small-molecule":[233],"developed":[235],"our":[237],"group.":[238],"further":[240,283],"demonstrate":[241],"significant":[242],"synergy":[243],"induction":[246],"induced":[249,289],"such":[258],"UM-101.":[260],"similar":[263],"way,":[264],"shown":[274],"cells":[277],"MEK":[280],"studied":[284],"mechanism":[286],"their":[295],"cellular":[296],"target":[297],"engagement.":[298],"These":[299],"studies":[300],"provide":[301],"evidence":[302],"targeting":[304],"represents":[306],"promising":[308],"strategy":[310],"treating":[312],"melanomas":[316],"aids":[318],"design":[321],"rational":[323],"before":[326],"acquired.":[329],"Citation":[330],"Format:":[331],"Karson":[332],"J.":[333],"Kump,":[334],"Lei":[335],"Miao,":[336],"Nurul":[337],"Ansari,":[338],"David":[339],"B.":[340],"Lombard,":[341],"Zaneta":[342],"Nikolovska-Coleska.":[343],"selectively":[346],"prime":[347],"dependence":[351],"sensitize":[353],"[abstract].":[357],"In:":[358],"Proceedings":[359],"American":[362],"Association":[363],"Cancer":[365,379],"Research":[366],"Annual":[367],"Meeting":[368],"2019;":[369],"2019":[370],"Mar":[371],"29-Apr":[372],"3;":[373],"Atlanta,":[374],"GA.":[375],"Philadelphia":[376],"(PA):":[377],"AACR;":[378],"Res":[380],"2019;79(13":[381],"Suppl):Abstract":[382],"nr":[383],"324.":[384]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2022-05-12T00:00:00"}